---
title: "深入分析 Heamonetics 近期的空頭頭寸"
description: "Haemonetics 的 HAE 空頭頭寸佔流通股的比例自上次報告以來下降了 4.44%。該公司最近報告稱，短期售出股票數量為 350 萬股，佔所有可交易普通股的 11.84%"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251882388.md"
published_at: "2025-08-06T17:39:49.000Z"
---

# 深入分析 Heamonetics 近期的空頭頭寸

> Haemonetics 的 HAE 空頭頭寸佔流通股的比例自上次報告以來下降了 4.44%。該公司最近報告稱，短期售出股票數量為 350 萬股，佔所有可交易普通股的 11.84%

Haemonetics's HAE short percent of float has fallen 4.44% since its last report. The company recently reported that it has 3.50 million shares sold short, which is 11.84% of all regular shares that are available for trading.

### Related Stocks

- [HAE.US - Heamonetics](https://longbridge.com/zh-HK/quote/HAE.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness | Haemonetics (HAE) has attracted investor interest following a significant share price decline, despite positive annual r | [Link](https://longbridge.com/zh-HK/news/276102791.md) |
| Skylands Capital LLC Has $3.97 Million Stock Holdings in Haemonetics Corporation $HAE | Skylands Capital LLC increased its stake in Haemonetics Corporation (NYSE:HAE) by 195.4% in Q3, owning 81,369 shares val | [Link](https://longbridge.com/zh-HK/news/275611703.md) |
| Mizuho Markets Americas LLC Has $6.45 Million Stake in Haemonetics Corporation $HAE | Mizuho Markets Americas LLC reduced its stake in Haemonetics Corporation (NYSE:HAE) by 43.9% in Q3, now holding 132,314  | [Link](https://longbridge.com/zh-HK/news/272973905.md) |
| EQT Sells Vivasure Medical to Haemonetics for Up to EUR 185 Million | Haemonetics Corporation has acquired Vivasure Medical Limited for up to EUR 185 million, including an upfront payment of | [Link](https://longbridge.com/zh-HK/news/272225988.md) |
| Where Haemonetics Stands With Analysts | Haemonetics (NYSE:HAE) has received mixed evaluations from 11 analysts over the past three months, with an average 12-mo | [Link](https://longbridge.com/zh-HK/news/272283620.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。